2m 2m 2m 2m 2m 2m 2m
RANI THERAP-A (RANI)
NASDAQ
$0.62+$0.03 (+5.34%)
Price as of Oct 23, 2026 7:46 AM EDT- $67.8MMarket Cap
- -71.89%1-Year Change
- BiotechnologyIndustry
RANI THERAP-A (RANI)
$0.62+$0.03 (+5.34%)
RANI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.59 | ||
Change | -$0.02 (-2.88%) | ||
Open | $0.62 | ||
High | $0.63 | ||
Low | $0.57 | ||
Previous Close | $0.60 | ||
Volume | 773,552 | ||
30-Day Average Volume | 570,751 | ||
1-Week Change | -13.59% | ||
1-Month Change | -24.46% | ||
1-Year Change | -71.89% | ||
3-Year Change | -70.47% | ||
5-Year Change | -96.83% | ||
Fundamentals | |||
Shares Outstanding | 115.4M | ||
Total Assets | $60.8M | ||
Market Cap | $67.8M | ||
Enterprise Value | $63.0M | ||
Period: QTR TTM FY | |||
Revenue | $1.7M | ||
Net Income | -$7.4M | ||
Free Cash Flow | -$9.1M | ||
EBIT | -$7.4M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $45.9M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 2 | ||
P/E | -15 | ||
PEG | N/A | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue